Chronic Lymphocytic Leukemia (CLL)
Showing NaN - NaN of 7
Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
-
La Jolla, California
- +41 more
Aug 10, 2022
Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)
Completed
- Cutaneous T-cell Lymphoma (CTCL)
- +4 more
-
Duarte, California
- +18 more
Nov 19, 2020
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Idelalisib, Rituximab)
Terminated
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
-
La Jolla, California
- +5 more
Oct 19, 2018
Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Rituximab, Bendamustine, MEDI-551)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- Rituximab
- +2 more
-
Birmingham, Alabama
- +53 more
Apr 20, 2017
Chronic Lymphocytic Leukemia (CLL) Trial in La Jolla (Lenalidomide)
Withdrawn
- Chronic Lymphocytic Leukemia (CLL)
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Apr 26, 2017
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in La Jolla, Columbus, Houston (plerixafor)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
-
La Jolla, California
- +2 more
Mar 19, 2015
Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Idelalisib, Rituximab)
Approved for marketing
- Chronic Lymphocytic Leukemia (CLL)
-
La Jolla, California
- +7 more
Oct 27, 2014